Abstract Details
|
Jeffrey R. Vitt, MD
(University of California, Davis)
PRESENTER |
Dr. Vitt has nothing to disclose. |
| Ali G. Hamedani, MD, MHS (Hospital of the University of Pennsylvania) | Dr. Hamedani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Hamedani has received personal compensation in the range of $0-$499 for serving as a Consultant for LoQus23. The institution of Dr. Hamedani has received research support from NIH. The institution of Dr. Hamedani has received research support from Biogen. The institution of Dr. Hamedani has received research support from Biohaven. |
| Sarah Horn, MD (UT Health San Antonio) | Dr. Horn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Horn has received research support from Alzheimer's Association. |
| Kimberly Gannon, MD, PhD (Chrisiana Care Health Services - Vascular Neurology) | No disclosure on file |
| Raymond Price, MD, FAAN (University of Pennsylvania) | Dr. Price has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Price Lakeside. Dr. Price has received publishing royalties from a publication relating to health care. |
| Maxwell A. Greene, MD (Stanford Neurology) | Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Dysimmune Diseases Foundation . |